Quoin Pharmaceuticals Ltd

QNRX

Company Profile

  • Business description

    Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.

  • Contact

    42127 Pleasant Forest Court
    AshburnVA20148-7349
    USA

    T: +1 703 980-4182

    https://www.quoinpharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2024

    Employees

    4

Stocks News & Analysis

stocks

Undervalued ASX share pulls a rabbit out of a hat

First quarter results are strong and debt levels have dropped.
stocks

The best tech stocks to buy

10 undervalued stocks offer attractive prices in a predominantly overvalued sector.
stocks

Microsoft earnings: Strength in cloud, guidance mixed

We think investors should be on board when Azure accelerates in the third quarter.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,403.7024.000.29%
CAC 407,409.1158.740.80%
DAX 4019,254.97177.430.93%
Dow JONES (US)42,052.19288.730.69%
FTSE 1008,177.1567.050.83%
HKSE20,460.2446.19-0.23%
NASDAQ18,239.92144.770.80%
Nikkei 22538,053.671,027.58-2.63%
NZX 50 Index12,584.7925.510.20%
S&P 5005,728.8023.350.41%
S&P/ASX 2008,144.2025.400.31%
SSE Composite Index3,264.427.60-0.23%

Market Movers